您当前的位置: 首页 > 资源详情

SSRN,2月20日,Clinical Characteristics and Treatment of Patients Infected with COVID-19 in Shishou, China

编译者:zhangmin发布时间:Feb 21, 2020点击量:42740 来源栏目:最新研究

Clinical Characteristics and Treatment of Patients Infected with COVID-19 in Shishou, China

27 Pages Posted: 20 Feb 2020

Xiongwei Qin

The People's Hospital of Shishou

Shaohong Qiu

The People's Hospital of Shishou

Abstract

Background: (NCP) Novel coronavirus pneumonia that recently occurred in Hubei Province, China is caused by a new type of coronavirus (new coronavirus in 2019) (COVID-19)1-4 . Our research object is patients living in Shishou, Hubei Province, Shishou is a city about 300 kilometers away from Wuhan. The characteristics of patients in this city are different from those in Wuhan. We report the epidemiological and clinical characteristics of patients in this city, laboratory and radiological characteristics, as well as treatment and clinical outcomes. We also focus on how we treat the disease, how to treat it with antibiotics, hormones etc. to achieve a higher cure rate. In particular, we introduced the role of methylprednisolone in the treatment of ICU patients. The methylprednisolone protocol was developed by Wuhan Union Hospital and certified by the Chinese Ministry of Health.

提供服务:导出本资源
  1. 1 Nature,11月10日,Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility
  2. 2 11月10日_研究人员分析宿主基因对COVID-19严重程度和易感性的影响
  3. 3 11月11日_新冠药物Remestemcel-L二期临床的中期分析结果积极
  4. 4 11月11日_CDC呼吁制定通用口罩规定以减少新冠传播
  5. 5 SSRN,2月20日,Dynamics of the Latest 2019 Novel Coronavirus Disease Epidemic in China: A Descriptive Study
  6. 6 SSRN,2月20日,Mental Health Problems and Social Media Exposure During COVID-19 Outbreak
  7. 7 SSRN,2月20日,Evaluating Incidence and Impact Estimates of the Coronavirus Outbreak from Official and Non-Official Chinese Data Sources
  8. 8 SSRN,2月20日,Clinical Characteristics and Treatment of Patients Infected with COVID-19 in Shishou, China
  9. 9 Nature,11月10日,Mobility network models of COVID-19 explain inequities and inform reopening
  10. 10 1月27日_Nature报道中国新型冠状病毒最新研究进展:病毒传播速度有多快?
  1. 1 Medicalxpress,1月10日,Even symptom-free, people with Omicron are much more likely to spread COVID, say studies
  2. 2 Medicalxpress,1月10日,Researchers use artificial intelligence to guide the search for the next SARS-like virus
  3. 3 1月6日_COVID-19患者味觉改变可能是鼻后嗅觉功能受损的间接结果
  4. 4 Medicalxpress,1月7日,Omicron resistant to most monoclonal antibodies but neutralized by a booster dose
  5. 5 Science,1月6日,Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
  6. 6 Biospace,1月5日,Clover Doses First Participants with Homologous Booster Dose of COVID-19 Vaccine Candidate in SPECTRA
  7. 7 Medicalxpress,1月4日,Early data for multivariant COVID-19 vaccine booster shows promise
  8. 8 Cell,1月3日,SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
  9. 9 Medicalxpress,12月30日,Research team discovers a novel vaccine strategy to prevent SARS-CoV-2 nasal infection
  10. 10 Cell,12月27日,Complement activation induces excessive T cell cytotoxicity in severe COVID-19

版权所有@2017中国科学院文献情报中心

制作维护:中国科学院文献情报中心信息系统部地址:北京中关村北四环西路33号邮政编号:100190